back to overview


New investment in an Israeli based digital health company TytoCare

February 23, 2018 + Jessica Di Palo
5 Min read

MTIP Expands TytoCare Funding Round to $25M, Joining an International Syndicate for the telehealth Start-up.

Tytocare closes investment round

MTIP joins a large list of strategic and financial investors to expand a funding round for TytoCare, an Israel-based digital health company with breakthrough technology for conducting comprehensive examinations and telehealth visits, to $28M. Additional investors include Ping An Global Voyager Fund, Cambia Health Solutions, Walgreens, Orbimed, Fosun Pharma, LionBird and Qure.  As the sole European based investor, MTIP is working with TytoCare to help them expand in the European region.

Following its FDA clearance in late 2016, and the launch of its products in the United States in early 2017, TytoCare has gained significant traction with major US health systems, telehealth companies, large private practices and employers. TytoCare will use the additional funding to continue its expansion in the US market and enhance its product offerings and smart data analytics to empower both clinicians and consumers doing telehealth. The funds will also help TytoCare fulfil the demand for its products outside the US and penetrate both the Asian and European markets.

MTIP has played and will continue to play a vital role in opening doors and creating potential partnerships throughout Europe,” said Dedi Gilad, Co-Founder and CEO of TytoCare. “Building on the success and excitement for TytoCare in the US, we are pleased to be partnering with such a knowledgeable digital health investor whose unique position will help us further transform telehealth and reach more homes around the globe, especially in Europe.”

“TytoCare has an exceptional telehealth solution that will revolutionize how patients receive primary care,” said Dr Christoph Kausch Founding Partner and CEO of MTIP.  “The quality of the management team is exceptional and we look forward to taking part in TytoCare’s success.”

Bruce Meadows, the Fund’s Senior Investment Director, added that “TytoCare fits perfectly into MTIP’s digital health strategy.  Their connected suite of tools is at the intersection of telehealth and medical devices. Their ability to generate clinical quality data combined with machine learning produces better outcomes for patients and cost efficiency for healthcare systems.”

Share the Article


SFDR Art. 8 or Art. 9? What’s the difference?

SFDR: getting the terminology right


MTIP participates in Oviva’s new $80m Series C funding

Oviva raises $80 million financing round


MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence

MTIP's new investment in Intelligencia


Private Equity 101: Part one – Glossary

Are you new to the healthtech space?


Leading brands revolutionize care journeys with Lumeon

How Lumeon orchestrates care journey


Trialbee – our hero in patient matching and recruiting for clinical trials

Trialbee - patient matching and recruiting

news blog

Digital healthcare: patient-first?

Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital

SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?

New SFDR obligations


MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation

First Closing of Fund II


How to pitch to a healthtech Investor

Blog Pitching


MTIP invests in Koa Health to make mental health treatment more accessible

New investment in Koa Health


MTIP scored fantastic grades in the UNPRI assessment report of 2020

UNPRI Report grades 2020


4 Health VCs Share Their Business Priorities and What is Next

Interview Techtour


MTIP invests in Trialbee

New investment in Trialbee


TytoCare closes $50 million round as the demand for telehealth accelerates

TytoCare closes new round


The digital healthtech sector is expanding – and so are we!

Two new empolyees start in April


MTIP has sucessfully exited Blueprint Genetics

Blueprint exit January 2020


New MTIP investment in Oviva

New investment in Oviva


Whitepaper: A positive prognosis for the future of healthtech

Our first Whitepaper


Elite Summit 2019 – Interview with our Managing Partner Christoph Kausch

Elite Summit 2019


MTIP Healthcare Clinic 2019

Healthcare clinic 2019

New MTIP investment in Cynerio

New investment in Cynerio


MTIP invests in Lumeon Ltd.

New investment in Lumeon

Magenverkleinerung mit der Handnähmaschine

Nitinotes news paper article


New MTIP investment in Quanta Dialysis Technologies

New investment in Quanta